Viral Vectors Made Accessible

We aim to provide cost effective gene therapy treatments to every patient in need

Learn More

A collaborative approach

We are dedicated to supporting our clients through every stage of the development journey, cultivating trust and transparency throughout the process.

Read More

Leadership

Junwei Sun

Co-Founder & Advisor

Learn More

Dr. Shangzhen Zhou

Co-Founder & CTO

Learn More

Our Leadership

VintaBio was founded by innovators with unique insights and know-how.

Our capabilities

(RUO) Vector material

Under the direction of our founder, Dr. Shangzhen Zhou, we produce high quality vectors for use in research & discovery utilizing our legacy platform that deliver unparalleled potency.

Learn More

Toxicology material

Our platform provides a turn-key solution for the entire viral vector manufacturing process, from cell banking to drug product.

Learn More

cGMP material

Speed to clinic paired with right-first-time execution is in our DNA. Our integrated supply chain and standard documentation strategies greatly reduce GMP readiness timelines and ensure unparalleled focus on the nuances of your program.

Learn More
All capabilities

Our Platform

Our super-producing AAV platform provides the most vector per dollar without compromise.  At its core is a proprietary cell line and transfection method that produces 1E17 total vg, making it applicable to even the most dose-demanding indications.

 Learn more about our capabilities